These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27422900)

  • 1. TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells.
    Palladino G; Notarangelo T; Pannone G; Piscazzi A; Lamacchia O; Sisinni L; Spagnoletti G; Toti P; Santoro A; Storto G; Bufo P; Cignarelli M; Esposito F; Landriscina M
    Endocr Relat Cancer; 2016 Sep; 23(9):699-709. PubMed ID: 27422900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors.
    Condelli V; Piscazzi A; Sisinni L; Matassa DS; Maddalena F; Lettini G; Simeon V; Palladino G; Amoroso MR; Trino S; Esposito F; Landriscina M
    Cancer Res; 2014 Nov; 74(22):6693-704. PubMed ID: 25239454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
    Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
    FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.
    Costantino E; Maddalena F; Calise S; Piscazzi A; Tirino V; Fersini A; Ambrosi A; Neri V; Esposito F; Landriscina M
    Cancer Lett; 2009 Jun; 279(1):39-46. PubMed ID: 19217207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.
    Maddalena F; Sisinni L; Lettini G; Condelli V; Matassa DS; Piscazzi A; Amoroso MR; La Torre G; Esposito F; Landriscina M
    Mol Oncol; 2013 Oct; 7(5):895-906. PubMed ID: 23735188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.
    Sisinni L; Maddalena F; Lettini G; Condelli V; Matassa DS; Esposito F; Landriscina M
    Int J Oncol; 2014 Feb; 44(2):573-82. PubMed ID: 24297638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.
    Sisinni L; Maddalena F; Condelli V; Pannone G; Simeon V; Li Bergolis V; Lopes E; Piscazzi A; Matassa DS; Mazzoccoli C; Nozza F; Lettini G; Amoroso MR; Bufo P; Esposito F; Landriscina M
    J Pathol; 2017 Sep; 243(1):123-134. PubMed ID: 28678347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
    Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
    Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
    Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
    Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
    J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.
    Maddalena F; Simeon V; Vita G; Bochicchio A; Possidente L; Sisinni L; Lettini G; Condelli V; Matassa DS; Li Bergolis V; Fersini A; Romito S; Aieta M; Ambrosi A; Esposito F; Landriscina M
    Oncotarget; 2017 Mar; 8(13):21229-21240. PubMed ID: 28177905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
    Breinig M; Mayer P; Harjung A; Goeppert B; Malz M; Penzel R; Neumann O; Hartmann A; Dienemann H; Giaccone G; Schirmacher P; Kern MA; Chiosis G; Rieker RJ
    Clin Cancer Res; 2011 Apr; 17(8):2237-49. PubMed ID: 21372220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models.
    Lin SF; Lin JD; Hsueh C; Chou TC; Yeh CN; Chen MH; Wong RJ
    Oncotarget; 2017 Jun; 8(25):41294-41304. PubMed ID: 28476040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
    Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
    Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAP1: a viable therapeutic target for future cancer treatments?
    Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
    Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases.
    Liu D; Hu J; Agorreta J; Cesario A; Zhang Y; Harris AL; Gatter K; Pezzella F
    Cancer Lett; 2010 Oct; 296(2):194-205. PubMed ID: 20471161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.
    Agliarulo I; Matassa DS; Amoroso MR; Maddalena F; Sisinni L; Sepe L; Ferrari MC; Arzeni D; Avolio R; Paolella G; Landriscina M; Esposito F
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2570-9. PubMed ID: 26071104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.